Filing Details
- Accession Number:
- 0000950170-24-001035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-03 16:54:23
- Reporting Period:
- 2023-12-29
- Accepted Time:
- 2024-01-03 16:54:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1785173 | 89Bio Inc. | ETNB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1423327 | Rohan Palekar | C/O 89Bio, Inc. 142 Sansome Street, 2Nd Floor San Francisco CA 94104 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-12-29 | 50,000 | $1.93 | 351,225 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-12-29 | 50,000 | $11.20 | 301,225 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-12-29 | 50,000 | $0.00 | 50,000 | $1.93 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
145,231 | 2028-11-09 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 275 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2023.
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023.
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.035 to $11.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This option is vested in full.